sPCMA Business Forum 2020

March 16 & 17 at the Hilton Bonnet Creek Orlando, FL

Cancelled Due To The COVID-19 Pandemic

Unfortunately, the sPCMA Business Forum 2020 was cancelled and not held as planned due to the COVID-19 pandemic. View the official PCMA statement here.

The sPCMA Business Forum hosts payer-aligned specialty pharmacies and their business partners – payers, PBMs, drug manufacturers, and others. Speakers are among the specialty pharmacy industry’s top thought leaders and the Business Forum hosts the most specialty drug management decision makers of any industry conference.

Conference Program Book

sPCMA Business Forum 2020 Agenda

Monday, March 16
7:00 am – 7:00 pm

Registration Open

7:00 am – 6:30 pm

Private Meeting Rooms Open

7:00 am – 9:00 am

Networking Breakfast

9:00 am – 12:00 pm

General Sessions

Conference Moderator:  Ian Spatz, Senior Advisor, Manatt Health

 

9:00 am – 9:15 am

Welcome and Opening Remarks

JC Scott, President & Chief Executive Officer, PCMA

 

9:15 am – 10:00 am

PBM and Pharma Collaboration: Focusing on Patients and Value

Shontelle Dodson, Senior Vice President, Health Systems, Astellas

Jarrod Henshaw, Senior Vice President, Chief Supply Chain and Industry Relations Officer, Prime Therapeutics

Kate Larkin, Senior Vice President, US Value, Access, Payment and fHEOR, Bristol-Myers Squibb

Everett Neville, Executive Vice President, Strategy, Supply Chain & Specialty, Express Scripts

Moderator: Ian Spatz, Senior Advisor, Manatt Health

 

10:00 am – 10:45 am

The Current State and Future Evolution of the Medicare Part D Program

Chris Stewart, Associate Vice President, Public Policy, Humana Pharmacy Solutions

Mike Anderson, Chief Executive Officer, Medicare Part D, OptumRx

Derek Asay, Senior Director, Government Strategy, Lilly USA

Moderator: Ian Spatz, Senior Advisor, Manatt Health

 

10:45 am – 11:30 am

Utilization Management Strategies: How Total Cost of Care and the Drug Pipeline are Bringing Change 

Caroline Carney, Chief Medical Officer, Magellan Rx Management

Sharon Glave Frazee, Senior Vice President, Research and Data Innovation, Pharmacy Benefit Management Institute

Savitha Vivian, Senior Vice President, Clinical and Formulary Services, OptumRx

Moderator: Ian Spatz, Senior Advisor, Manatt Health

 

11:30 am – 12:15 pm

Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases

Raquel Cabo, Vice President, Global Market Access and Patient Services, Ovid Therapeutics

Jessica Ciccolella-Kahl, Senior Director, Product Management, Accredo

Amanda Moore, Chief Executive Officer, Angelman Syndrome Foundation

Moderator: Tom Knox, President, Fathom Healthcare Solutions, Inc.

12:15 pm - 1:45 pm

Networking Lunch & 

Member Company Lunch Receptions: Ascent Health, Humana Pharmacy Solutions & MedImpact Healthcare Systems

These receptions offer excellent opportunities for interactions between PBM and SP members, drug manufacturers, and other industry partners. Attendees flow in and out of the concurrent receptions while members serve as hosts in their designated room during the reception time.

1:45 pm - 2:15 pm

Breakout Sessions (two concurrent)

 

The Long Game Strategy for Transforming Pharmacy from Volume to Value  – A Call to Action for all Stakeholders

Chronis Manolis, Senior Vice President, Chief Pharmacy Officer, UPMC Health Plan

cpe-icon_web_40x40

 

Using Technology to Enhance Care for Complex Patients 

Eleanor Chye, Vice President, PBM Product Development, CVS Health

cpe-icon_web_40x40

2:15 pm - 2:30 pm

Break

2:30 pm - 3:00 pm

Breakout Sessions (two concurrent)

 

Personal Connected Care Enables Clinical Guarantees

Snezana Mahon, Vice President & General Manager Clinical Solutions, Express Scripts

cpe-icon_web_40x40

 

Commercializing Specialty Products: A 2020 Perspective

Kevin Cast, Partner, Archbow

Dave MacLeod, Head of Patient Services and Specialty Pharmacy Operations, Amylyx Pharmaceuticals

cpe-icon_web_40x40

3:00 pm - 3:15 pm

Break

3:15 pm - 3:45 pm

Personal Career Development Series: The Family Office – Financial Planning Strategies for Busy Executives

Matthew Topley, Chief Investment Officer, Fortis Wealth

6:30 pm - 9:00 pm

Cocktail and Dinner Reception with Live Music

Live music, food stations, and an outdoor ambiance provide a relaxed and fun atmosphere — perfect for business networking during this evening reception.

Tuesday, March 17
7:00 am - 4:00 pm

Registration Open

7:00 am - 8:00 pm

Private Meeting Rooms Open

7:30 am - 9:00 am

Networking Breakfast & 

Member Company Breakfast Receptions: Envolve Pharmacy Solutions, Magellan Rx Management & Prime Therapeutics

These receptions offer excellent opportunities for interactions between PBM and SP members, drug manufacturers, and other industry partners. Attendees flow in and out of the concurrent receptions while members serve as hosts in their designated room during the reception time.

9:00 am - 11:30 am

General  Sessions

 

9:00 am – 9:30 am

PBM’s Role in Future Healthcare Environment – Leveraging Data, Making Total Cost of Care a Reality, and Continued Drug Trend Management   

Alan Lotvin, President, CVS Caremark and Executive Vice President, CVS Health

 

9:30 am – 10:15 am

Encouraging a Robust US Biosimilars Marketplace: What’s Best for Payers, Patients and Drug Makers?

Farrah Wong, Senior Director, Commercial Formulary Contracting Strategy, OptumRx

Sheila Frame, Vice President, Marketing, Market Access and Patient Services, Sandoz
Moderator: Ian Spatz, Senior Advisor, Manatt Health

 

10:15 am – 11:00

Putting Patients First: How Specialty Pharmacy Evolves to Meet Patient Care Needs

Michael Zeglinski, Senior Vice President, Specialty Pharmacy, OptumRx

Kollet Koulianos, Senior Director Payer Relations, National Hemophilia Foundation

 

11:00 am – 11:30 am

Specialty Pharmaceuticals: Trends & Outlook

Doug Long, Vice President, Industry Relations, IQVIA

11:30 am - 1:00 pm

Networking Lunch &  

Member Company Lunch Receptions: CVS Health, Express Scripts & OptumRx

These receptions offer excellent opportunities for interactions between PBM and SP members, drug manufacturers, and other industry partners. Attendees flow in and out of the concurrent receptions while members serve as hosts in their designated room during the reception time.

1:00 pm - 1:30 pm

Breakout Sessions (two concurrent)

Specialty Pharmacy Credentialing to Optimize Patient Care and Outcomes

Jonah Houts, Vice President, Provider Contracting and Strategy, Express Scripts

cpe-icon_web_40x40

 

Future Impact and Considerations for Value Frameworks

Richard Willke, Chief Scientific Officer, ISPOR

cpe-icon_web_40x40

1:30 pm - 1:45 pm

Break

1:45 pm - 2:15 pm

Breakout Sessions (two concurrent)

 

Future Proofing Pharmacy

Harry Travis, President & CEO, etectRx

cpe-icon_web_40x40

 

Setting Expectations for High Cost Innovative Therapies: Can Payers and Life Science companies achieve a Win-Win? 

Shirley Bachman, Vice President, US Market Access, Alnylam Pharmaceuticals

Kim Gwiazdzinski, Vice President, Value and Access, Coeus Consulting Group

Brian Ragan, Value-based Contracting Executive, Humana Pharmacy Solutions

3:30 pm - 5:00 pm

Influential Leadership: Communicating with Today’s Short Attention Span Listeners

– Brought to you by the PCMA Women’s Leadership Initiative

Christine Marsh, Senior Vice President, Market Access, Boehringer Ingelheim

Patricia Scott, Ph.D., President and Chief Executive Officer, Uhmms LLC

Bethanie Stein, Vice President, Strategic Contracting, Purchasing, and Analytics, Humana Pharmacy Solutions

8:00 pm - 10:00 pm

Cocktail and Dessert Reception

Join your peers for dessert, cocktails, and conversation with colleagues at this after-dinner reception.